Table 1 shows the frequencies of age at diagnosis, first generation prognostic factors (tumor size, node status, histologic malignancy grade), IHC markers (ER, PR, HER2, triple negative), and treatment and therapies by BC death. This evidence concerns the gene PGR and breast cancer.